Ariel Poler
Team Member @ Kongregate
San Francisco, United States
Ariel Poler is a seed investor at Kongregate in San Francisco focused on Software and Social Media. Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 4%
Last updated:
For AI agents: llms.txt
Industries Ariel Poler invests in
Stages Ariel Poler invests in
Countries Ariel Poler invests in
Round sizes
Round size
- Seed
- $455k–$7M
- Angel
- $1M–$1.7M
- Series A
- $3M–$7.9M
Investment Focus
Industry
- Software 10 (22%)
- Social Media 9 (20%)
- Internet 8 (18%)
- Apps 7 (16%)
- Mobile 7 (16%)
Stage
- Seed 15 (33%)
- Series A 14 (31%)
- Angel 6 (13%)
- Pre-Seed 3 (7%)
- Funding Round 2 (4%)
Country
- United States 34 (76%)
- Spain 2 (4%)
- Mexico 2 (4%)
- United Kingdom 2 (4%)
- Chile 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management. | $3.8M / Convertible Note / Oct 05, 2021 | |
|
|
Reloadly makes it easy for developers to connect with Mobile operator services. We are disrupting a Trillion dollar industry! Mobile Operators are stuck in old school business models, where most of the world is moving to open source platforms for developers to build amazing products. Reloadly is bridging the gap between mobile operators anddevelopers, and at the same time creating new sales channels for the 816 mobile operators around the world. | $4.4M / Series A / Jul 18, 2021 | |
|
|
Openlytics is a Visual Data Platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape the direction ofthe product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io. | $1.2M / Pre-Seed / Apr 15, 2021 | |
|
|
humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.humm is working to bring the incredible results of neuroscience research out of the lab and into non-invasive wearables that improve the quality of life for everyday people. Our first product is a clinically validated patch that you wearfor 15 minutes to get up to 90 minutes of improved working memory, by gently stimulating the signals in the part of the brain that controls your executive thinking. humm improves your ability to learn and be at your best, allowing people to reconnect with the joy of learning and challenge themselves to continue growing at any stage of life, whether it's for work or personal enjoyment! | $130K / Pre-Seed / May 30, 2019 | |
|
|
BIOS Health uses data-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer forprecision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology and medicine. Advisors include Oxford University Professors David Paterson and Tim Denison, CEO of Candel Therapeutics Paul Peter Tak, and IQVIA VP of Genomic and Precision Medicine Joanne Hackett (Chair of the BIOS Board). | $4.5M / Seed / Dec 04, 2018 | |
|
|
Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America. | $7M / Seed / Jul 30, 2018 | |
|
|
Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America. | $7M / Seed / Jun 28, 2018 | |
|
|
The Podcast App is an audio platform that helps millions of people in their pursuit of happiness. Under one roof, we bring the best and most powerful podcasts, audiobooks, and meditations from leading minds and experts around the world. | Seed / Jan 04, 2018 | |
|
|
Kiwi Campus, often referred to as Kiwi, is an on demand convenience service that delivers what you need, day or night. Our Kiwibots - cute little delivery robots - deliver right up to your doorstep. Kiwibot is making deliveries more affordable and accessible for communities. We're helping people with deliveries that are cheaper and faster thanever before. Kiwibots mesh seamlessly within the fabric of our sidewalks and empower anyone to get anything they want in under 30 minutes. | Angel / Jul 01, 2017 | |
|
|
BIOS Health uses data-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer forprecision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology and medicine. Advisors include Oxford University Professors David Paterson and Tim Denison, CEO of Candel Therapeutics Paul Peter Tak, and IQVIA VP of Genomic and Precision Medicine Joanne Hackett (Chair of the BIOS Board). | Seed / Mar 20, 2017 | |
| See all 45 investments → | |||
Co-Investors
About Kongregate
Jim and Emily Greer started Kongregate 10 years ago with the vision of creating an open platform for indie games with a strong focus on community engagement. Since inception, Kongregate has always prioritized treating developer partners fairly and honestly. This means great games for our players and an engaged audience for our developers. Now, adecade after its introduction, Kongregate is a leading mobile game publisher and web gaming portal. Through our mobile publishing program, we work closely with game developers to provide a multitude of services to help great games become even better. Kongregate’s mobile games have been downloaded tens of millions of times and have hundreds of millions of gameplays. Kongregate's web portal features over 100,000 free games played by tens of millions of players per month.In November 2018 Kongregate launched Kartridge, a community-driven PC gaming platform focused on indie games. The platform is designed to help game developers of all sizes find success, offering them full control over their games, including deciding their own pricing model and customizing the user experience within the Kartridge ecosystem.
Kongregate Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ariel Poler
Team Member
|
|||
|
David Mata
Kongregate
|
|||
|
Markus Lipp
Interim CEO
|
|||
|
Melinda Montano
Business Development Manager
|
|||
|
Tamara Levy
Chief Product Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Featured in Investor Lists
Recommended lists
FAQ
What does Ariel Poler invest in?
Ariel Poler invests primarily in Software, Social Media and Internet startups, most often at Seed and Series A stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ariel Poler's check size?
Ariel Poler typically joins rounds of $455k–$7M at Seed, $1M–$1.7M at Angel and $3M–$7.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ariel Poler participates in.
When did Ariel Poler last invest?
The most recent investment recorded for Ariel Poler closed in Oct 2021. Shizune tracks 45 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!